Athira Pharma, Inc. — Form D/A
Athira Pharma, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2019-01-23. The offering totals $2.0M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-01-23
- Form: D/A
- Accession: 0001620463-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.3M
- Remaining: $734K
- Investors: 10
- Date of first sale: 2018-12-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-328537
Issuer
- Name: Athira Pharma, Inc.
- CIK: 0001620463
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 4000 MASON ROAD, SUITE 300, SEATTLE, WA, 981952141
- Phone: 5095927191
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Michael M Montgomery | Director | Seattle, WA |
| MICHAEL MONTGOMERY | Director | LITTLE ROCK, AR |
| Leen Kawas | Director | Los Angeles, CA |
| Leen Kawas | Executive Officer | Los Angeles, CA |
| Leen Kawas | Promoter | Los Angeles, CA |
| Jay Wright | Director | Potomac, MD |
| Jay Wright | Promoter | Potomac, MD |
| Joseph M Edelman | Director | Seattle, WA |
| John M Fluke, Jr. | Director | Seattle, WA |
| Tadataka M Yamada | Director | Seattle, WA |
| Mark M Litton | Executive Officer | Seattle, WA |
| Joseph W Harding | Director | Seattle, WA |
| Christina M Thomson | Executive Officer | Seattle, WA |
| Glenna M Mileson | Executive Officer | Seattle, WA |
| Hansjoerg M Moebius | Executive Officer | Seattle, WA |
| John Fluke | Director | Seattle, WA |
| John Fluke | Executive Officer | Seattle, WA |
| John Fluke | Promoter | Seattle, WA |
| Joseph Harding | Director | Seattle, WA |
| Joseph Harding | Executive Officer | Seattle, WA |
| Joseph Harding | Promoter | Seattle, WA |
| Bruce Montgomery | Director | Seattle, WA |
Other filings by this issuer (9)
More